Free Newsletter
FEATURES >> The most interesting logos in Pharma
Vermont mulls free-sample disclosure rule
Vermont, which has already reined in drugmakers' marketing, could become the first state to require pharma to report how much they're spending on free drug samples. Report
Comments
With over half of the population in VT on VT medicaid, VT should welcome drug samples as these samples keep many of their residents on the medications that they need.
That is a great idea. This practice would show transparency to all. As a professional in health care I see the positive impact medicine and device companies provide everyday for patients. These companies are the most regulated companies in the world, yet the made out to be the enemy. Not only will the American public can see the millions of dollars that are put into free samples, they may also understand the investment and time put into the development of new medicines and technologies.
Post new comment
Paid Research Reports
- Cloud Computing Adoption In The APAC Life Sciences Industry
- Pharmaceutical Licensing Overview
- Stakeholder Opinions: Vaccines in emerging markets (Latin America) - Opportunities in Brazil, Mexico and Argentina
- Pharmaceutical Key Trends 2010
- Commercial Insight: Top 20 Oncology Therapy Brands in Australia
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities



SHARE
WITH: